Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311005140> ?p ?o ?g. }
- W4311005140 endingPage "2665" @default.
- W4311005140 startingPage "2665" @default.
- W4311005140 abstract "Sibiriline is a novel drug inhibiting receptor-interacting protein 1 kinase (RIPK1) and necroptosis, a regulated form of cell death involved in several disease models. In this study, we aimed to investigate the metabolic fate of sibiriline in a cross-sectional manner using an in silico prediction, coupled with in vitro and in vivo experiments. In silico predictions were performed using GLORYx and Biotransformer 3.0 freeware; in vitro incubation was performed on differentiated human HepaRG cells, and in vivo experiments including a pharmacokinetic study were performed on mice treated with sibiriline. HepaRG culture supernatants and mice plasma samples were analyzed with ultra-high-performance liquid chromatography, coupled with tandem mass spectrometry (LC-HRMS/MS). The molecular networking bioinformatics tool applied to LC-HRMS/MS data allowed us to visualize the sibiriline metabolism kinetics. Overall, 14 metabolites, mostly produced by Phase II transformations (glucuronidation and sulfation) were identified. These data provide initial reassurance regarding the toxicology of this new RIPK1 inhibitor, although further studies are required." @default.
- W4311005140 created "2022-12-22" @default.
- W4311005140 creator A5001793044 @default.
- W4311005140 creator A5008966469 @default.
- W4311005140 creator A5017583905 @default.
- W4311005140 creator A5027582606 @default.
- W4311005140 creator A5034767927 @default.
- W4311005140 creator A5056016094 @default.
- W4311005140 creator A5057338223 @default.
- W4311005140 creator A5059155407 @default.
- W4311005140 creator A5071754418 @default.
- W4311005140 date "2022-11-30" @default.
- W4311005140 modified "2023-10-17" @default.
- W4311005140 title "A Transversal Approach Combining In Silico, In Vitro and In Vivo Models to Describe the Metabolism of the Receptor Interacting Protein 1 Kinase Inhibitor Sibiriline" @default.
- W4311005140 cites W1899693663 @default.
- W4311005140 cites W1980455299 @default.
- W4311005140 cites W1989299822 @default.
- W4311005140 cites W2015466394 @default.
- W4311005140 cites W2027254129 @default.
- W4311005140 cites W2027974246 @default.
- W4311005140 cites W2028040738 @default.
- W4311005140 cites W2069457036 @default.
- W4311005140 cites W2077692978 @default.
- W4311005140 cites W2084015767 @default.
- W4311005140 cites W2098547087 @default.
- W4311005140 cites W2103581045 @default.
- W4311005140 cites W2159675211 @default.
- W4311005140 cites W2163891284 @default.
- W4311005140 cites W2167456918 @default.
- W4311005140 cites W2271921484 @default.
- W4311005140 cites W2282846152 @default.
- W4311005140 cites W2504691963 @default.
- W4311005140 cites W2584580415 @default.
- W4311005140 cites W2599487050 @default.
- W4311005140 cites W2625396968 @default.
- W4311005140 cites W2734615175 @default.
- W4311005140 cites W2766254647 @default.
- W4311005140 cites W2770156192 @default.
- W4311005140 cites W2796012599 @default.
- W4311005140 cites W2809045056 @default.
- W4311005140 cites W2888972338 @default.
- W4311005140 cites W2900981302 @default.
- W4311005140 cites W2901755966 @default.
- W4311005140 cites W2907470641 @default.
- W4311005140 cites W2910665987 @default.
- W4311005140 cites W2913519090 @default.
- W4311005140 cites W2914574343 @default.
- W4311005140 cites W2938858702 @default.
- W4311005140 cites W2941122504 @default.
- W4311005140 cites W3004624101 @default.
- W4311005140 cites W3015424183 @default.
- W4311005140 cites W3016864886 @default.
- W4311005140 cites W3048674038 @default.
- W4311005140 cites W3091140219 @default.
- W4311005140 cites W3099658142 @default.
- W4311005140 cites W3108739976 @default.
- W4311005140 cites W3154083735 @default.
- W4311005140 cites W3159031703 @default.
- W4311005140 cites W3186256245 @default.
- W4311005140 cites W3200697332 @default.
- W4311005140 cites W4200090159 @default.
- W4311005140 cites W4286213450 @default.
- W4311005140 doi "https://doi.org/10.3390/pharmaceutics14122665" @default.
- W4311005140 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36559159" @default.
- W4311005140 hasPublicationYear "2022" @default.
- W4311005140 type Work @default.
- W4311005140 citedByCount "2" @default.
- W4311005140 countsByYear W43110051402023 @default.
- W4311005140 crossrefType "journal-article" @default.
- W4311005140 hasAuthorship W4311005140A5001793044 @default.
- W4311005140 hasAuthorship W4311005140A5008966469 @default.
- W4311005140 hasAuthorship W4311005140A5017583905 @default.
- W4311005140 hasAuthorship W4311005140A5027582606 @default.
- W4311005140 hasAuthorship W4311005140A5034767927 @default.
- W4311005140 hasAuthorship W4311005140A5056016094 @default.
- W4311005140 hasAuthorship W4311005140A5057338223 @default.
- W4311005140 hasAuthorship W4311005140A5059155407 @default.
- W4311005140 hasAuthorship W4311005140A5071754418 @default.
- W4311005140 hasBestOaLocation W43110051401 @default.
- W4311005140 hasConcept C104317684 @default.
- W4311005140 hasConcept C155138218 @default.
- W4311005140 hasConcept C184235292 @default.
- W4311005140 hasConcept C185592680 @default.
- W4311005140 hasConcept C202751555 @default.
- W4311005140 hasConcept C207001950 @default.
- W4311005140 hasConcept C2775905019 @default.
- W4311005140 hasConcept C2779907587 @default.
- W4311005140 hasConcept C54355233 @default.
- W4311005140 hasConcept C55493867 @default.
- W4311005140 hasConcept C70721500 @default.
- W4311005140 hasConcept C86803240 @default.
- W4311005140 hasConcept C87644729 @default.
- W4311005140 hasConcept C95444343 @default.
- W4311005140 hasConcept C98274493 @default.
- W4311005140 hasConceptScore W4311005140C104317684 @default.
- W4311005140 hasConceptScore W4311005140C155138218 @default.
- W4311005140 hasConceptScore W4311005140C184235292 @default.
- W4311005140 hasConceptScore W4311005140C185592680 @default.